NEW YORK (GenomeWeb) — Foundation Medicine said today that the company has been added to the Nasdaq Biotechnology Index. 

The index tracks Nasdaq-listed securities that are classified as either biotechnology or pharmaceutical by the Industry Classification Benchmark. The index, which is reranked each year, is also the basis for the iShares Nasdaq Biotechnology Index Fund. The fund seeks investment results corresponding generally to the price and yield performance of the Nasdaq Biotechnology Index, and options based on the index fund trade on various exchanges. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.